Drugs / imipenem/cilastatin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT02191475 Comparator | May 2014 → May 2017 | digestive system infectious disorder | Tianjin Medical University Cancer Institute and Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | imipenem/cilastatin | “dose of imipenem/cilastatin 500mg, IVdrip” NCT02191475 ↗ |
| Route | Intravenous | “dose of imipenem/cilastatin 500mg, IVdrip” NCT02191475 ↗ |